Constellation Pharmaceuticals Inc (CNST) Stock News
NASDAQ:CNST - Nasdaq -
CNST Latest News, Press Relases and Analysis
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) ("MorphoSys") today announced the successful completion of its previously announced cash tender offer for all outstanding shares of Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) ("Constellation") for $34.00 per share, net to
Mentions: MOR
A Buy the Dip Stock Trigger in Constellation Pharmaceuticals Inc
The Techncial Trigger Driven Stock Trade in Constellation Pharmaceuticals Inc (NASDAQ:CNST) .
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), for its tender offer for Constellation Pharmaceuticals, Inc., (NASDAQ:CNST) ("Constellation"). The expiration of the HSR waiting period satisfies one of the conditions to the tender offer, which is
Mentions: MOR
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 28, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Core-Mark Holding Company, Inc. (NASDAQ:CORE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Performance Food Group Company. Under the terms of the merger, Core-Mark shareholders will receive $23.875 per share in cash and
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Meridian Bancorp, Inc. (NASDAQ:EBSB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Independent Bank Corp. Under the terms of the agreement, Meridian Bancorp stockholders will receive 0.2750 of a share of Independent Bank
J.P. Morgan Downgrades Constellation Pharmaceuticals (CNST) to Hold
Mentions: JPM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to MorphoSys AG for $34.00 per share in cash. If you are a Constellation shareholder, click here to learn more about your
Biogen's FDA Win Marks a Mini-Rally in Biotech Stocks
Biotech stocks are surging in June on a raft of upbeat news from Biogen. It's a turnaround from a spring drubbing.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSSI, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 10, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Diamond S Shipping Inc. (NYSE:DSSI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to International Seaways, Inc. Under the merger agreement, Diamond S shareholders will receive 0.55375 shares of International Seaways common
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST
Mentions: MOR
The Top-Returning IPOs of the Pandemic
A biotech. A shipper. A sporting goods chain. A home builder. There are many paths to IPO success.